Welireg (Belzutifan)

Welireg is a hypoxia-inducible factor inhibitor used to treat adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring prompt surgery.  

Recommended Dosage: The recommended dosage is 120 mg administered orally (by mouth) once daily until the disease is progressive or unacceptable toxicity occurs. Welireg must be taken at the same time every day and may be taken with or without meal. Patients should swallow the Welireg tablets whole, without chewing, crushing, or splitting. 

If a dose is missed/skipped, it can be taken as promptly as possible on the same day. Resume the regular daily dose schedule the very next day. Do not take additional tablets to make up for the missed/skipped dose. 

In case vomiting occurs any time after taking the dosage, avoid retaking the dose. Patients should take the next scheduled dose on the very next day.

• Welireg 40 mg tablets can cause severe anemia that can require blood transfusion. Monitor for anemia prior to initiation of, and periodically throughout, therapy with Welireg. Precisely assess those who are dual UGT2B17 & CYP2C19 poor metabolizers because of potential increases in exposure that may increase the incidence or severity of anemia.
• Consideration of erythropoiesis stimulating agents (ESAs) to treat anemia is not recommended in those treated with Belzutifan. For those treated with Belzutifan who develop anemia, the safety as well as effectiveness for use of erythropoiesis stimulating agents have not been established.
• Belzutifan can cause serious hypoxia that may require interruption, supplemental oxygen, or hospitalization. Monitor oxygen saturation prior to initiation of, and periodically throughout, therapy with Belzutifan. For decreased oxygen saturation with exercise (pulse oximeter <88% or PaO2 ≤55 mm Hg), consider withholding Belzutifan until pulse oximetry with exercise is beyond 88%, then resume at the same dose or at a decreased dose.
• For reduced oxygen saturation at rest (pulse oximeter <88% or PaO2 ≤55 mm Hg) or urgent intervention indicated, withhold treatment with Belzutifan 40 mg tablets until resolved and resume at a decreased dose or discontinue. For life-threatening hypoxia or for recurrent symptomatic hypoxia, permanently discontinue treatment. Patients must report signs/symptoms of hypoxia promptly to a health specialist.
• Welireg can cause fetal harm if administered to a pregnant woman. Verify the pregnancy status of females of reproductive age prior to starting therapy with Welireg. Females of reproductive age should use apt non-hormonal contraception during therapy with Welireg and for 7 days after the final dose. This medicine can render some hormonal contraceptives ineffective. 

What documents are required to import WELIREG to India?

WELIREG (belzutifan) tablets can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

1. A valid prescription from a qualified doctor.
2. Patients diagnostic reports
3. Patients ID Proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

1. A valid prescription from a Doctor
2. Import permit if applicable

Is WELIREG available in India?

WELIREG (belzutifan tablet) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input on:

1. Availability of Welireg in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune, etc.)
2. Medicine Price
3. Finding genuine and reliable sources from Canada, Europe, USA, and Australia
4. Ensuring 100% transparency

WELIREG can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of WELIREG (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write to us at info@indianpharmanetwork.in for Welireg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is proficient in sourcing WELIREG (Cancer Treatment Medicines) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.

Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.

What is the Generic Name for the trade name drug Welireg®?

Belzutifan is the Generic Name for the trade name drug Welireg®.

What is the Manufacturer Name of Welireg®?

Welireg® is manufactured by Merck.

Is Welireg® approved by the FDA?

Yes, Welireg® is approved by the FDA. Date of first/initial approval: August 13, 2021.

Where can I get Welireg® at the best price in India?

To get the best Welireg (Belzutifan) price in India, kindly contact Indian Pharma Network (a WHO GDP & ISO 9001:2008 certified company). For Welireg®, a valid medical prescription is required from your treating physician.

What is the dosage and form of Welireg® supplied?

Welireg® is supplied as Tablets: 40 mg for oral administration.

What are the most common side effects with Welireg®?

The most common side effects with Welireg® include: anemia, fatigue, decreased hemoglobin, increased creatinine, headache, increased glucose, dizziness, and nausea.

How much does Welireg® cost in India?

The cost of Welireg in India is less and can vary. In order to procure this medication authentically, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Welireg®?

Store at room temperature between 68°F to 77°F (20°C to 25°C). The bottle contains two desiccant canisters that help keep your medication dry. Never eat the desiccant canisters.

Is it safe to buy Welireg® online from India?

Yes, you can buy Welireg tablets online at the best price from the Indian Pharma Network (IPN) if Welireg® has not been approved or is not available in your country.